CC
STJ

Carlson Capital’s St Jude Medical STJ Stock Holding History

Carlson Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,030,000
Closed -$243M – 359
2016
Q4 		$243M Buy
3,030,000
+354,000
+13% +$28.1M 2.91% 1
2016
Q3 		$213M Buy
2,676,000
+625,000
+30% +$50.5M 2.7% 2
2016
Q2 		$160M Buy
+2,051,000
New +$146M 1.99% 7
2015
Q1 		– Sell
-306,474
Closed -$19.9M – 396
2014
Q4 		$19.9M Buy
+306,474
New +$19.7M 0.2% 160
2014
Q3 		– Sell
-198,170
Closed -$13.7M – 391
2014
Q2 		$13.7M Sell
198,170
-249,300
-56% -$16.2M 0.15% 202
2014
Q1 		$29.3M Buy
+447,470
New +$29.1M 0.34% 99

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Carlson Capital's STJ Position: Q1 2017 in Review

Carlson Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,030,000 shares — an estimated $243M sold.

Carlson Capital first reported a position in STJ in Q1 2014 and held it in 6 quarters. The position peaked at $243M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Carlson Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Carlson Capital sold 3,030,000 St Jude Medical shares in Q1 2017, an estimated $243M.
  • Carlson Capital first reported a position in St Jude Medical in Q1 2014 and held it in 6 quarters.
  • Carlson Capital's St Jude Medical position peaked at $243M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Carlson Capital's 13F filing for Q1 2017, filed 15 May 2017.